SLGL — SOL-GEL TECHNOLOGIES Share News
0.000.00%
Last trade - 00:00- $227.38m
- $179.45m
- $19.39m
SOL-GEL TECHNOLOGIES LTD. expected to post a loss of $2.57 a share - Earnings Preview
Sol-Gel Q1 revenue falls sharply on milestone payment impact
Brief: Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand
Brief: Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering
NASDAQ RESUMED AT 10:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:59 AM
NASDAQ RESUMED AT 09:50 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM
Brief: Sol Gel Technologies Ltd Phase 3 Trial Of Sgt-610 For Gorlin Syndrome Is Ongoing,Top-Line Results Expected Q4 2026
Brief: Sol-Gel And Mayne Pharma Announce The Purchase Of Epsolay And Twyneo In The U.S.
Sol Gel Technologies Ltd expected to post a loss of 11 cents a share - Earnings Preview
Brief: Sol-Gel Announces 180-Day Extension To Regain Compliance With Nasdaq Minimum Bid Requirement
Sol Gel Technologies Ltd reports results for the quarter ended September 30 - Earnings Summary
Sol Gel Technologies Ltd expected to post a loss of 13 cents a share - Earnings Preview
Sol Gel Technologies Ltd reports results for the quarter ended in January - Earnings Summary
Sol Gel Technologies Ltd expected to post a loss of 20 cents a share - Earnings Preview
Sol Gel Technologies Ltd expected to post a loss of 20 cents a share - Earnings Preview
Brief: Sol-Gel Announces Receipt Of Nasdaq Minimum Price Notice
Brief: Sol-Gel, Beimei Pharma Announce Asset Purchase Agreement